Bolton Securities’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-27,000
Closed -$567K – 2106
2025
Q4
$567K Hold
27,000
– – 0.03% 504
2025
Q3
$417K Buy
+27,000
New +$387K 0.02% 558

Other funds holding RGC

Bolton Securities's RGC Position: Q1 2026 in Review

Bolton Securities sold out of Regencell Bioscience (RGC) in Q1 2026, closing a stake of 27,000 shares — an estimated $567K sold.

Bolton Securities first reported a position in RGC in Q3 2025 and held it in 2 quarters. The position peaked at $567K in Q4 2025. 33 funds tracked by Wall St. Rank hold RGC as of Q1 2026.

  • Bolton Securities reported no remaining Regencell Bioscience position as of Q1 2026 after selling out during the quarter.
  • Bolton Securities sold 27,000 Regencell Bioscience shares in Q1 2026, an estimated $567K.
  • Bolton Securities first reported a position in Regencell Bioscience in Q3 2025 and held it in 2 quarters.
  • Bolton Securities's Regencell Bioscience position peaked at $567K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Regencell Bioscience as of Q1 2026.

Based on Bolton Securities's 13F filing for Q1 2026, filed 12 Nov 2026.